Submitted by Anonymous (not verified) on 9 September 2024 - 16:02
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab, Date of authorisation: 18/11/2020, Revision: 3, Status: Withdrawn (authorisation)
Source: